We are live on ! Find out more
EHI

Eagle Health Investments Portfolio holdings

AUM $603M
1-Year Est. Return 111.06%
This Fund
S&P 500
This Quarter Est. Return
+6.38%
1 Year Est. Return
+111.06%
3 Year Est. Return
+240.87%
5 Year Est. Return
+290.92%
10 Year Est. Return
–
AUM
$514M
AUM Growth
+$80.2M
Cap. Flow
+$80.5M
Cap. Flow %
15.67%
Top 10 Hldgs %
68.1%
Holding
30
New
3
Increased
9
Reduced
4
Closed
3

Top Buys

Rank Stock Value
1
LNTH icon
Lantheus
LNTH
+$18.4M
2
SRPT icon
Sarepta Therapeutics
SRPT
+$18M
3
GH icon
Guardant Health
GH
+$15.1M
4
ILMN icon
Illumina
ILMN
+$14.6M
5
PRCT icon
Procept Biorobotics
PRCT
+$10M

Top Sells

Rank Stock Value
1
CTLT
CATALENT, INC.
CTLT
+$14.8M
2
TNDM icon
Tandem Diabetes Care
TNDM
+$6.83M
3
ALNY icon
Alnylam Pharmaceuticals
ALNY
+$3.99M
4
TXG icon
10x Genomics
TXG
+$1.79M
5
NTRA icon
Natera
NTRA
+$1.44M

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ILMN icon
1
Illumina
ILMN
$29B
$48.2M 9.39%
213,281
+71,505
+50% +$14.6M
IQV icon
2
IQVIA
IQV
$40B
$45M 8.77%
226,495
+22,400
+11% +$4.79M
NTRA icon
3
Natera
NTRA
$46.4B
$43.6M 8.48%
784,894
-30,100
-4% -$1.44M
ISRG icon
4
Intuitive Surgical
ISRG
$138B
$36.6M 7.12%
143,090
+34,860
+32% +$8.59M
SGEN
5
DELISTED
Seagen Inc. Common Stock
SGEN
$35.4M 6.89%
174,902
– –
ICLR icon
6
Icon
ICLR
$12.9B
$33.3M 6.48%
155,900
+32,800
+27% +$7.3M
UTHR icon
7
United Therapeutics
UTHR
$22.7B
$29.4M 5.72%
131,238
– –
ALNY icon
8
Alnylam Pharmaceuticals
ALNY
$29B
$27.4M 5.33%
136,756
-18,960
-12% -$3.99M
DXCM icon
9
DexCom
DXCM
$33.2B
$26.9M 5.24%
231,600
+12,600
+6% +$1.41M
ARGX icon
10
argenx
ARGX
$54.2B
$24M 4.67%
64,400
+4,100
+7% +$1.52M
INSP icon
11
Inspire Medical Systems
INSP
$1.73B
$23.8M 4.63%
101,543
– –
LNTH icon
12
Lantheus
LNTH
$6.59B
$23.5M 4.58%
+284,800
New +$18.4M
OM icon
13
Outset Medical
OM
$94M
$22.1M 4.3%
80,026
-1,348
-2% -$495K
SRPT icon
14
Sarepta Therapeutics
SRPT
$1.79B
$19.1M 3.72%
+138,640
New +$18M
TNDM icon
15
Tandem Diabetes Care
TNDM
$1.57B
$17.3M 3.36%
425,525
-164,975
-28% -$6.83M
GH icon
16
Guardant Health
GH
$22.8B
$14M 2.72%
596,561
+530,001
+796% +$15.1M
ADPT icon
17
Adaptive Biotechnologies
ADPT
$4.09B
$10.7M 2.09%
1,214,860
+607,000
+100% +$5.35M
PRCT icon
18
Procept Biorobotics
PRCT
$1.26B
$8.07M 1.57%
+284,218
New +$10M
FDMT icon
19
4D Molecular Therapeutics
FDMT
$572M
$7.53M 1.47%
437,911
– –
AGIO icon
20
Agios Pharmaceuticals
AGIO
$1.94B
$6.15M 1.2%
267,630
– –
CANO
21
DELISTED
Cano Health, Inc.
CANO
$3.9M 0.76%
42,909
+40,706
+1,848% +$5.53M
AMWL icon
22
American Well
AMWL
$232M
$3.29M 0.64%
69,752
– –
CMAX
23
DELISTED
CareMax, Inc. Class A Common Stock
CMAX
$1.91M 0.37%
23,825
– –
OLK
24
DELISTED
Olink Holding AB (publ) American Depositary Shares
OLK
$901K 0.18%
40,000
– –
BEAM icon
25
Beam Therapeutics
BEAM
$2.82B
$885K 0.17%
28,900
– –
1
2

Similar funds

PIFP
Partners in Financial Planning Salem, Virginia $603M AUM 12.72% 1-Year Est. Return
IECM
Intrinsic Edge Capital Management Chicago, Illinois $603M AUM 66.97% 1-Year Est. Return
ERWM
Elk River Wealth Management Denver, Colorado $602M AUM 22.77% 1-Year Est. Return
CIG
Capricorn Investment Group Palo Alto, California $602M AUM 165.22% 1-Year Est. Return
JHCP
Jackson Hole Capital Partners Tulsa, Oklahoma $605M AUM 22.77% 1-Year Est. Return
TCM
Topline Capital Management Santa Monica, California $605M AUM 26.24% 1-Year Est. Return
NPCM
North Peak Capital Management New York $601M AUM 0.2% 1-Year Est. Return
OCAM
Onex Canada Asset Management Toronto, Ontario, Canada $601M AUM 15.16% 1-Year Est. Return

Eagle Health Investments's Q1 2023 Portfolio in Review

As of Q1 2023, Eagle Health Investments held 30 positions worth $514M, up 19% from $433M the previous quarter. Its ten largest holdings account for 68% of the portfolio.

Eagle Health Investments deployed $80.5M of net new capital in Q1 2023, opening 3 new positions and adding to 9 existing holdings. Its largest new stake was Lantheus: 284,800 shares worth $23.5M.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

On the sell side, the largest reduction was Tandem Diabetes Care, an estimated $6.83M trimmed.

  • Eagle Health Investments's largest Q1 2023 buy was Lantheus: 284,800 shares worth $23.5M.
  • Eagle Health Investments added most to Guardant Health in Q1 2023, an estimated $15.1M increase.
  • Eagle Health Investments's biggest Q1 2023 reduction was Tandem Diabetes Care, cutting an estimated $6.83M.
  • Eagle Health Investments fully exited CATALENT, INC. in Q1 2023, selling an estimated $14.8M.
  • Eagle Health Investments's ten largest holdings make up 68% of its $514M portfolio in Q1 2023.
  • Eagle Health Investments opened 3 new positions and closed 3 in Q1 2023.
  • Eagle Health Investments's portfolio value rose 19% quarter-over-quarter to $514M.

Based on Eagle Health Investments's 13F filing for Q1 2023, filed 12 May 2023.